LEXARIA BIOSCIENCE CORP. Liabilities, Noncurrent
LEXARIA BIOSCIENCE CORP. (LEXX) had Liabilities, Noncurrent of $142.59 thousand as of 2023-05-31, per its 10-Q filed 2023-07-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2023-07-14
- 2023-05-31: Liabilities, Noncurrent $142.59K.
- 2023-02-28: Liabilities, Noncurrent $0.00.
- 2022-11-30: Liabilities, Noncurrent $0.00.
- 2022-08-31: Liabilities, Noncurrent $7.40K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2023-05-31 | $142.59K 10-Q · filed 2023-07-14 |
| 2023-02-28 | $0.00 10-Q · filed 2023-04-14 |
| 2022-11-30 | $0.00 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | $7.40K 10-Q · filed 2023-07-14 |
| 2022-05-31 | $18.34K 10-Q · filed 2022-07-14 |
| 2022-02-28 | $29.08K 10-Q · filed 2022-04-11 |
| 2021-11-30 | $39.63K 10-Q · filed 2022-01-14 |
| 2021-08-31 | $49.99K 10-K · filed 2022-11-28 |
| 2021-05-31 | $60.16K 10-Q · filed 2021-07-15 |
| 2021-02-28 | $70.16K 10-Q · filed 2021-04-14 |
| 2020-11-30 | $110.82K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $120.06K 10-K · filed 2021-11-29 |
| 2020-05-31 | $28.76K 10-Q · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |